Income Taxes - Additional Information (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
| Valuation Allowance [Line Items] | ||
| Decrease in valuation allowance | $ 1,200,000 | |
| Deferred tax asset, net of tax liability related to basis difference in foreign subsidiaries | 7,000,000 | |
| Basis difference in foreign subsidiaries | 11,600,000 | |
| Income tax expense | 0 | $ 0 |
| Deferred tax assets | 0 | |
| Uncertain tax positions | 0 | $ 0 |
| Federal | ||
| Valuation Allowance [Line Items] | ||
| Tax deduction from compensation expense | $ 252,000 | |
| X | ||||||||||
- Definition Deferred Tax Asset, Net of Deferred Tax Liability Related to Basis in Difference in Foreign Subsidiaries No definition available.
|
| X | ||||||||||
- Definition Deferred Tax Liabilities, Basis Difference in Foreign Subsidiaries No definition available.
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|